Evaluating your Retrieval Augmented Generation (RAG) system to make sure it fulfils your business requirements is paramount before deploying it to production environments. However, this requires acquiring a high-quality dataset of real-world question-answer pairs, which can be a daunting task, especially in the early stages of development. This is whereContinue Reading
Generative artificial intelligence (AI) models have opened up new possibilities for automating and enhancing software development workflows. Specifically, the emergent capability for generative models to produce code based on natural language prompts has opened many doors to how developers and DevOps professionals approach their work and improve their efficiency. InContinue Reading
Today, we are excited to announce the availability of the Llama 3.1 405B model on Amazon SageMaker JumpStart, and Amazon Bedrock in preview. The Llama 3.1 models are a collection of state-of-the-art pre-trained and instruct fine-tuned generative artificial intelligence (AI) models in 8B, 70B, and 405B sizes. Amazon SageMaker JumpStartContinue Reading
In the diverse toolkit available for deploying cloud infrastructure, Agents for Amazon Bedrock offers a practical and innovative option for teams looking to enhance their infrastructure as code (IaC) processes. Agents for Amazon Bedrock automates the prompt engineering and orchestration of user-requested tasks. After being configured, an agent builds theContinue Reading
Stable Diffusion XL by Stability AI is a high-quality text-to-image deep learning model that allows you to generate professional-looking images in various styles. Managed versions of Stable Diffusion XL are already available to you on Amazon SageMaker JumpStart (see Use Stable Diffusion XL with Amazon SageMaker JumpStart in Amazon SageMakerContinue Reading
jetcityimage/iStock Editorial via Getty Images Eli Lilly’s (NYSE:LLY) newly approved Alzheimer’s drug Kisunla could generate peak sales of up to $7.1B for the company and will help diversify the drugmaker’s revenue stream, according to BMO. Kisunla, also known as donanemab, will be priced at $32,000 per year, with each vialContinue Reading
loooby/iStock via Getty Images The Hain Celestial Group (NASDAQ:HAIN) announced on Monday that it made a significant investment in a decarbonization project at its main UK manufacturing facility at Histon in Cambridgeshire, UK. Notably, Histon is the production site of many of the company’s most popular brands, including Hartley’s jamsContinue Reading
knowlesgallery/iStock Editorial via Getty Images Micron Technology (NASDAQ:MU) expects the sale of high bandwidth memory, or HBM, to expand from $100s of millions in revenue in fiscal year 2024 to billions in revenue by fiscal year 2025. “We expect to achieve HBM market share commensurate with our overall DRAM marketContinue Reading
